Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397)
02/2014
02/19/2014EP2697213A1 Inhibitors of viral replication, their process of preparation and their therapeutical uses
02/19/2014EP2697199A1 Aryl-or heteroaryl-substituted benzene compounds
02/19/2014EP2696688A1 Use of substituted dithiine-dicarboximides for combating phytopathogenic fungi
02/19/2014CN103596943A Hydantoin derivates as Kv3 inhibitors
02/19/2014CN103596942A Azole derivative, method for producing azole derivative, and intermediate compound
02/19/2014CN103596928A Neprilysin inhibitors
02/19/2014CN103596926A Fused tricyclic compounds as RAF kinase inhibitors
02/19/2014CN103588765A Synthesis method for azilsartan medoxomil or salt thereof, intermediate of azilsartan medoxomil or salt thereof and synthesis method for intermediate
02/19/2014CN103588764A Synthesis method for azilsartan medoxomil or salt thereof and intermediate of azilsartan medoxomil or salt thereof
02/19/2014CN103588758A Synthesis and preparation of nitroimidazole derivative containing 1,4-benzdioxan skeleton and application of nitroimidazole derivative in anticancer drugs
02/19/2014CN103588757A N-substituted imidazole carboxylic ester compound with ultrashort-acting anesthetic effect, preparation method and use thereof
02/19/2014CN103588739A Nitrofurans compounds, preparation method and application of nitrofurans compounds
02/19/2014CN103588718A Novel triazinedione derivatives as GABAB receptor modulators
02/19/2014CN103588704A Inhibitors of focal adhesion kinase
02/19/2014CN101679247B Process for the manufacture for non-steroidal anti-inflammatory agents and intermediates thereof
02/18/2014US8653270 Compounds as receptor modulators with therapeutic utility
02/18/2014US8653248 2-aminopyridine and 2-pyridone C-nucleosides
02/18/2014US8653112 Substituted pyrazoles as estrogen receptor ligands
02/18/2014US8653110 Active compound combination comprising azadirachtin and a substituted enaminocarbonyl compound
02/18/2014US8653062 Compounds as receptor modulators with therapeutic utility
02/18/2014CA2701594C Heterocycle phenyl amide t-type calcium channel antagonists
02/18/2014CA2659689C Amidine derivatives of 2-heteroaryl-quinazolines and quinolines; potent analgesics and anti-inflammatory agents
02/18/2014CA2577061C Histamine h3 receptor agents, preparation and therapeutic uses
02/18/2014CA2564076C Chemical linkers and conjugates thereof
02/13/2014WO2014026009A2 Inhibition of antimicrobial targets with reduced potential for resistance
02/13/2014WO2014025976A1 Heteroaromatic compounds as bruton's tyrosine kinase (btk) inhibitors
02/13/2014WO2014025891A1 Neprilysin inhibitors
02/13/2014WO2014025679A1 Process for the preparation of c-fms kinase inhibitors
02/13/2014WO2014025191A1 Novel tetrazolo hydrazine derivatives and pharmaceutical composition comprising same as active ingredient for preventing or treating cancer
02/13/2014WO2014024880A1 Organic electroluminescent element and electronic apparatus
02/13/2014WO2014024013A1 Pseudouridimycin (pum) and its derivates
02/13/2014WO2014023815A1 New antibacterial compounds
02/13/2014WO2014023814A1 New antibacterial compounds
02/13/2014WO2014023531A1 Trifluoromethylpyridine carboxamides as pesticides
02/13/2014WO2014023390A2 (aza-)isoquinolinone derivatives
02/13/2014WO2014023367A1 Carboxamide or sulfonamide substituted nitrogen-containing 5-membered heterocycles as modulators for the orphan nuclear receptor ror gamma
02/13/2014US20140045906 Neprilysin inhibitors
02/13/2014US20140045899 Prolyl hydroxylase inhibitors and methods of use
02/13/2014US20140045859 Glucokinase Activators
02/13/2014US20140045852 Substituted 4-aryl-n-phenyl-1,3,5-triazin-2-amines
02/13/2014US20140045849 Pyrimidine derivatives for the treatment of viral infections
02/13/2014US20140045825 Inhibitors of PI3K-Delta and Methods of Their Use and Manufacture
02/13/2014US20140045815 Indazole-3-carboxamides and their use as wnt/beta-catenin signaling pathway inhibitors
02/13/2014US20140045813 Heteroaromatic compounds as btk inhibitors
02/13/2014US20140045802 4-(4-cyano-2-thioaryl)dihydropyrimidinones and their use
02/13/2014US20140045793 Quinolone compound and pharmaceutical composition
02/13/2014US20140045789 Process for the preparation of c-fms kinase inhibitors
02/13/2014US20140044806 New positive allosteric modulators of nicotinic acetylcholine receptor
02/12/2014EP2695882A1 Organic compound, charge transport material, composition containing said compound, organic electroluminescent element, display device, and lighting device
02/12/2014EP2694707A1 Monomers capable of dimerizing in an aqueous solution, and methods of using same
02/12/2014EP2694619A1 Novel organic electroluminescent compounds and an organic electroluminescent device using the same
02/12/2014EP2694494A1 Fungicide hydroximoyl-tetrazole derivatives
02/12/2014EP2694492A1 Novel compounds as histamine h3 receptor ligands
02/12/2014EP2694484A1 Pyrimidine derivatives for the treatment of viral infections
02/12/2014EP2694482A1 Wnt pathway antagonists
02/12/2014EP2694481A1 Imidazole, pyrazole, and triazole derivatives useful as antibacterial agents
02/12/2014EP2694479A1 Process for the preparation of an hiv integrase inhibitor
02/12/2014EP2694475A1 Hydroxyphenyl pyrrole compounds containing an hydroxamic acid as hdac inhibitors and medicinal applications thereof
02/12/2014EP2694059A2 Small molecule inhibitors of xbp1 splicing
02/12/2014EP2693882A1 Substituted cyclopropyl compounds, compositions containing such compounds and methods of treatment
02/12/2014EP2693876A1 Substituted methylformyl reagents and method of using same to modify physicochemical and/or pharmacokinetic properties of compounds
02/12/2014CN103582637A Inhibitors of bruton's tyrosine kinase
02/12/2014CN103582632A 取代的苯并咪唑 Substituted benzimidazoles
02/12/2014CN103570729A Bicyclic neonicotine compounds constructed by cycloalkenone, and preparation method and application thereof
02/12/2014CN103570712A Phosphorescent compound and OLED using the same
02/12/2014CN103570699A Method for preparing prucalopride
02/12/2014CN103570698A Compound for preparing vilazodone as well as intermediate and application thereof
02/12/2014CN103570697A Method for preparing vilazodone and intermediate thereof
02/12/2014CN103570696A Method for preparing intermediate of axitinib and application of intermediate in preparation of axitinib
02/12/2014CN103570695A Preparation of icaritin and derivatives thereof and application of icaritin and derivatives of icaritin in radiotherapy
02/12/2014CN103570694A Preparation of icaritin and derivatives thereof and application of icaritin and derivatives of icaritin in tumor treatment
02/12/2014CN103570692A Quinazoline derivative with ethylene imine ring side chain as well as preparation and application
02/12/2014CN103570684A Phenylamine benzimidazole derivative and application of phenylamine benzimidazole derivative in preparation of anticoagulation medicine
02/12/2014CN103570653A Heterocyclic compound, organic light-emitting device including the same , and organic light-emitting display device
02/12/2014CN103570630A Heterocyclic nitrogen derivative and application thereof in medicines
02/12/2014CN103570625A N-(3-aryl-heteroaryl)-4-aryl-aryl carboxamide and analog as hedgehog pathway inhibitors and application thereof
02/12/2014CN103570614A Pyridine-2-hydrazide derivatives, preparation method, drug compositions and uses thereof
02/12/2014CN103566008A Saururus chinensis extract as well as preparation method and application thereof
02/12/2014CN101573354B Substituted isoquinolines and their use as Rho-kinase inhibitors
02/11/2014US8648069 5-substituted indazoles as kinase inhibitors
02/11/2014US8648067 Substituted phenoxypropylcycloamine derivatives as histamine-3 (H3) receptor ligands
02/11/2014CA2738563C 8-substituted isoquinoline derivatives and the use thereof
02/11/2014CA2536622C Inhibitors of cellular necrosis
02/11/2014CA2511199C Small molecule modulators of hepatocyte growth factor (scatter factor) activity
02/11/2014CA2501506C Modulation of anxiety through blockade of anandamide hydrolysis
02/06/2014WO2014021337A1 Compound and pharmaceutical composition for neuropsychological disorder or malignant tumor
02/06/2014WO2014021281A1 Partially saturated nitrogen-containing heterocyclic compound
02/06/2014WO2014020264A1 Novel iron complexes capable of detecting a nitro-reducing chemical or biochemical entity, in particular by in vivo mri, and in vitro detection method
02/06/2014WO2014020105A1 Griseofulvin derivatives
02/06/2014WO2014020101A1 Griseofulvin derivatives
02/06/2014WO2014019967A1 N-cyclopropyl-n-piperidinyl-amides, pharmaceutical compositions containing them and uses thereof
02/06/2014WO2014019442A1 Benzofuran derivatives, preparation method and medical use thereof
02/06/2014US20140039205 Method for Preparing Branched Functionalized Polymers Using Branched Polyol Cores
02/06/2014US20140039195 Squarylated Lactones Inhibitors for Bacterial Biofilm Formation
02/06/2014US20140039019 Methods of Using Ryanodine Antagonists in Treating Neural Injury
02/06/2014US20140038993 New compounds
02/06/2014US20140038979 Sulfonyl-derivatives as novel inhibitors of histone deacetylase
02/06/2014US20140038977 Pyridazin derivatives as antagonists of the bradykinin b1 receptor
02/06/2014US20140038965 5- and 6-membered heterocyclic compounds
02/06/2014US20140038964 Imidazole based lxr modulators
1 ... 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 ... 694